Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study.

MLA

Tanizaki, Satoshi, et al. “Sequencing Strategies with Ramucirumab and Docetaxel Following Prior Treatments for Advanced Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study.” European Journal of Clinical Pharmacology, vol. 79, no. 4, Apr. 2023, pp. 503–11. EBSCOhost, https://doi.org/10.1007/s00228-023-03452-0.

APA

Tanizaki, S., Matsumoto, K., Tamiya, A., Taniguchi, Y., Matsuda, Y., Uchida, J., Ueno, K., Kawachi, H., Tamiya, M., Yanase, T., Suzuki, H., & Okishio, K. (2023). Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study. European Journal of Clinical Pharmacology, 79(4), 503–511. https://doi.org/10.1007/s00228-023-03452-0

Chicago

Tanizaki, Satoshi, Kinnosuke Matsumoto, Akihiro Tamiya, Yoshihiko Taniguchi, Yoshinobu Matsuda, Junji Uchida, Kiyonobu Ueno, et al. 2023. “Sequencing Strategies with Ramucirumab and Docetaxel Following Prior Treatments for Advanced Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study.” European Journal of Clinical Pharmacology 79 (4): 503–11. doi:10.1007/s00228-023-03452-0.